Genalice proud winner of National ICT Innovation Award 2012
During a ceremony at the Grand Hotel Huis ter Duin in Noordwijk, the Netherlands, the winners of the National ICT~Awards 2012 were presented.
The annual ICT~Awards are an initiative of ICT~Office, the trade association composed of 550 IT, Telecom, Internet, and Office companies in the Netherlands.
Ordina won the ICT~Environment Award. The Commit Science Valorisation Prize 2012 was awarded to SecurityMatters. The ICT~Office Innovation Award went to Genalice. The National ICT~Awards highlight innovative ICT initiatives and encourage better and smarter use of ICT in business, non-profit sector and government organizations.
Genalice won the ICT~Office Innovation Award for its ‘Biomarker Discovery Platform for Oncology’. The jury was unanimous in its choice and wrote in their report: "This software platform helps medicine to perform faster, more reliable and cheaper analyses, to enhance the development of personalized treatments for cancer patients. The jury believes that Genalice is a wonderful example of how the world in the future may look, namely a compact company that collaborates with other private parties, science and medicine. They are working on a societal problem where the solution is not sought in 'big is better', but ‘smart is better’.”
"Bert Reijmerink, CEO of Genalice, is delighted with this prestigious award: "Winning this ICT~Office Innovation Award is another great boost to achieve our mission, where we seek to make the difference in the fight against cancer with technology. Our product offers a truly ‘game-changing’ contribution to significantly accelerate research into cancer and other DNA diseases."
Photo legend: Genalice wins Innovation Award 2012. From left to right: Harry van Dorenmalen (jury chairman), Bert Reijmerink (Genalice) and Jos Lunenberg (Genalice)
GENALICE is a young innovative software company, based in Harderwijk (the Netherlands). The mission of GENALICE is to improve and accelerate research into complex DNA-related diseases, such as cancer. By designing and developing groundbreaking software solutions GENALICE will make an important contribution to improved diagnosis and treatment of these diseases. One of these software solutions, GENALICE MAP, is a so-called short read alignment tool. MAP can process raw DNA data, produced by machines that read DNA, quickly, cost effective and reliable to a further analyzable small file. Its second product in development, GENALICE LINK, is a unique open platform for processing, integrating and correlating biomedical Big Data. On a standard hardware configuration all biomedical data of up to 150,000 patients can be analyzed within seconds. GENALICE hereby combines the robustness of the Oracle database with the performance and flexibility of customized software. The technology used is generally applicable, not only in the field of bioinformatics, but in all areas where reducing the data footprint and ultra-fast interpretation, transformation and correlation of data from different sources is important.
Contact Bert Reijmerink (Chief Strategy Officer)